Nitin Lifesciences
Investors Count
1Deal Terms
2Funding, Valuation & Revenue
2 Fundings
Nitin Lifesciences's latest funding round was a Acquired for $44.1M on January 3, 2018.
Nitin Lifesciences's valuation in October 2015 was $139.6M.
Nitin Lifesciences's latest post-money valuation is from January 2018.
Sign up for a free demo to see Nitin Lifesciences's valuations in January 2018 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/3/2018 | Acquired | $44.1M | 1 | |||
10/20/2015 | Corporate Majority | $139.6M |
Date | 1/3/2018 | 10/20/2015 |
|---|---|---|
Round | Acquired | Corporate Majority |
Amount | $44.1M | |
Investors | ||
Valuation | $139.6M | |
Revenue | ||
Sources | 1 |
Nitin Lifesciences Deal Terms
2 Deal Terms
Nitin Lifesciences's deal structure is available for 2 funding rounds, including their Acquired from January 03, 2018.
Round | Acquired | Corporate Majority |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Corporate Majority |
Nitin Lifesciences Investors
1 Investors
Nitin Lifesciences has 1 investors. Recipharm invested in Nitin Lifesciences's Acquired funding round.
Loading...